1. Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor–Negative: ASCO Guideline Update. Issue 35 (10th December 2021) Authors: Moy, Beverly; Rumble, R. Bryan; Come, Steven E.; Davidson, Nancy E.; Di Leo, Angelo; Gralow, Julie R.; Hortobagyi, Gabriel N.; Yee, Douglas; Smith, Ian E.; Chavez-MacGregor, Mariana; Nanda, Rita; McArthur, Heather L.; Spring, Laura; Reeder-Hayes, Katherine E.; Ruddy, Kathryn J.; Unger, Paul S.; V... Journal: Journal of clinical oncology Issue: Volume 39:Issue 35(2021) Page Start: 3938 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discordance in management of adverse events associated with oral therapies in hormone receptor–positive breast cancer among health care providers and experts: Findings from an online decision support tool. Issue 28 (1st October 2022) Authors: Rosenthal, Kristen M.; Brandt, Kelly G; Spring, Laura; Marti-Smith, Marissa; Quill, Timothy A.; O'Shaughnessy, Joyce Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Expert consensus recommendations for managing hyperglycemia and rash in patients with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) treated with alpelisib (ALP). Issue 28 (1st October 2022) Authors: Gallagher, Emily J.; Moore, Heather; Lacouture, Mario E.; Dent, Susan Faye; Farooki, Azeez; Goncalves, Marcus D.; Isaacs, Claudine; Johnston, Abigail; Juric, Dejan; Quandt, Zoe; Spring, Laura; Berman, Brian; Decker, Melanie; Hortobagyi, Gabriel N.; Kaffenberger, Benjamin; Kwong, Bernice Y.; Pluar... Journal: Journal of clinical oncology Issue: Volume 40:Issue 28(2022)Supplement Page Start: 422 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗